The oral chelator deferasirox--a new perspective for patients with iron overload
- PMID: 16818263
The oral chelator deferasirox--a new perspective for patients with iron overload
Comment on
-
Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload.Haematologica. 2006 Jul;91(7):873-80. Haematologica. 2006. PMID: 16818273 Clinical Trial.